Calumet (NASDAQ:CLMT) Director Sells $114,062.60 in Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 3,310 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total transaction of $114,062.60. Following the transaction, the director owned 81,958 shares in the company, valued at $2,824,272.68. The trade was a 3.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Calumet Stock Performance

Shares of Calumet stock opened at $35.06 on Friday. The company has a 50-day moving average of $28.20 and a two-hundred day moving average of $22.44. Calumet, Inc. has a 12-month low of $7.68 and a 12-month high of $36.94. The stock has a market cap of $3.04 billion, a PE ratio of -89.90 and a beta of 0.86.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.24. The firm had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.04 billion. During the same period last year, the firm earned ($0.47) EPS. Calumet’s revenue was up 9.4% compared to the same quarter last year. On average, sell-side analysts forecast that Calumet, Inc. will post -3.02 EPS for the current fiscal year.

Analyst Ratings Changes

CLMT has been the topic of several research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. The Goldman Sachs Group boosted their price objective on shares of Calumet from $24.00 to $34.00 and gave the stock a “buy” rating in a research report on Thursday, March 12th. TD Cowen increased their price objective on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, March 5th. HC Wainwright raised their target price on shares of Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a report on Monday, March 30th. Finally, UBS Group restated a “neutral” rating and set a $26.00 target price on shares of Calumet in a research report on Friday, February 13th. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $30.17.

Hedge Funds Weigh In On Calumet

Hedge funds have recently bought and sold shares of the stock. Covestor Ltd lifted its position in shares of Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after acquiring an additional 492 shares in the last quarter. O Keefe Stevens Advisory Inc. boosted its stake in shares of Calumet by 2.2% during the third quarter. O Keefe Stevens Advisory Inc. now owns 27,416 shares of the oil and gas company’s stock valued at $500,000 after acquiring an additional 599 shares during the last quarter. ProShare Advisors LLC increased its position in Calumet by 6.9% during the 4th quarter. ProShare Advisors LLC now owns 12,613 shares of the oil and gas company’s stock worth $251,000 after purchasing an additional 817 shares in the last quarter. Aster Capital Management DIFC Ltd increased its position in Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock worth $33,000 after purchasing an additional 1,229 shares in the last quarter. Finally, Islay Capital Management LLC acquired a new position in Calumet in the 4th quarter valued at about $25,000. Hedge funds and other institutional investors own 34.41% of the company’s stock.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.